container_type,source,bib,filled,author_pub_id,num_citations,citedby_url,cites_id,investigator
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Guillain-Barré syndrome related to COVID-19 infection', 'pub_year': '2020', 'citation': 'Neurology: Neuroimmunology & Neuroinflammation 7 (4), e741, 2020'}",False,UCoILMwAAAAJ:p__nRnzSRKYC,432,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5480433319160022943,['5480433319160022943'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings', 'pub_year': '2013', 'citation': 'Annals of Oncology 24 (2), 454-462, 2013'}",False,UCoILMwAAAAJ:roLk4NBRz8UC,346,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12951548016161422759,['12951548016161422759'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools', 'pub_year': '2010', 'citation': 'European journal of cancer 46 (3), 479-494, 2010'}",False,UCoILMwAAAAJ:LkGwnXOMwfcC,321,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14291351477000495345,['14291351477000495345'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer', 'pub_year': '2013', 'citation': 'Cancer 119 (2), 438-444, 2013'}",False,UCoILMwAAAAJ:UebtZRa9Y70C,263,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13672052654549347680,['13672052654549347680'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire', 'pub_year': '2018', 'citation': 'Health and quality of life outcomes 16, 1-15, 2018'}",False,UCoILMwAAAAJ:HE397vMXCloC,213,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6586311881955062365,['6586311881955062365'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin', 'pub_year': '2014', 'citation': 'Annals of oncology 25 (1), 257-264, 2014'}",False,UCoILMwAAAAJ:MXK_kJrjxJIC,177,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6679570352071513716,['6679570352071513716'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients', 'pub_year': '2014', 'citation': 'Journal of Neurology, Neurosurgery & Psychiatry 85 (4), 392-398, 2014'}",False,UCoILMwAAAAJ:3fE2CSJIrl8C,168,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17526230930847566755,['17526230930847566755'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics', 'pub_year': '2011', 'citation': 'The lancet oncology 12 (12), 1151-1161, 2011'}",False,UCoILMwAAAAJ:Se3iqnhoufwC,144,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4596101804950442783,['4596101804950442783'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced neuropathy', 'pub_year': '2011', 'citation': 'Current treatment options in neurology 13, 180-190, 2011'}",False,UCoILMwAAAAJ:hqOjcs7Dif8C,132,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11029643221087048401,['11029643221087048401'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Voltage‐gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin‐induced peripheral neurotoxicity: Results from a prospective multicenter study', 'pub_year': '2013', 'citation': 'Cancer 119 (19), 3570-3577, 2013'}",False,UCoILMwAAAAJ:8k81kl-MbHgC,130,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3329346695603462460,['3329346695603462460'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients', 'pub_year': '2012', 'citation': 'Annals of oncology 23 (12), 3116-3122, 2012'}",False,UCoILMwAAAAJ:0EnyYjriUFMC,123,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=98471627847139555,['98471627847139555'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase IIa clinical trial', 'pub_year': '2018', 'citation': 'Neurotherapeutics 15 (1), 178-189, 2018'}",False,UCoILMwAAAAJ:dshw04ExmUIC,115,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6563821362356712830,['6563821362356712830'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Long‐term course of oxaliplatin‐induced polyneuropathy: a prospective 2‐year follow‐up study', 'pub_year': '2014', 'citation': 'Journal of the Peripheral Nervous System 19 (4), 299-306, 2014'}",False,UCoILMwAAAAJ:4TOpqqG69KYC,104,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17492146864047572810,['17492146864047572810'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings', 'pub_year': '2019', 'citation': 'Journal of Neurology, Neurosurgery & Psychiatry 90 (12), 1361-1369, 2019'}",False,UCoILMwAAAAJ:ZfRJV9d4-WMC,91,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4889243876952786810,['4889243876952786810'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy‐induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale', 'pub_year': '2011', 'citation': 'Journal of the peripheral nervous system 16 (3), 228-236, 2011'}",False,UCoILMwAAAAJ:5nxA0vEk-isC,83,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=18214996476996623639,['18214996476996623639'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24, S13-S25, 2019'}",False,UCoILMwAAAAJ:0KyAp5RtaNEC,76,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12248607038705921855,['12248607038705921855'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy‐induced peripheral neurotoxicity: A multifaceted, still unsolved issue', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24, S6-S12, 2019'}",False,UCoILMwAAAAJ:nrtMV_XWKgEC,74,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9806503580291015867,['9806503580291015867'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity', 'pub_year': '2018', 'citation': 'The Journal of clinical investigation 128 (2), 816-825, 2018'}",False,UCoILMwAAAAJ:mvPsJ3kp5DgC,69,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8570828189891424039,['8570828189891424039'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy', 'pub_year': '2018', 'citation': 'Experimental neurology 307, 129-132, 2018'}",False,UCoILMwAAAAJ:WA5NYHcadZ8C,68,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5464076375549127866,['5464076375549127866'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Bortezomib and other proteosome inhibitors—induced peripheral neurotoxicity: From pathogenesis to treatment', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24, S52-S62, 2019'}",False,UCoILMwAAAAJ:XD-gHx7UXLsC,67,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7940157559778239792,['7940157559778239792'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24, S63-S73, 2019'}",False,UCoILMwAAAAJ:t7zJ5fGR-2UC,67,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5772093879257928220,['5772093879257928220'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Taxane and epothilone‐induced peripheral neurotoxicity: from pathogenesis to treatment', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24, S40-S51, 2019'}",False,UCoILMwAAAAJ:yB1At4FlUx8C,63,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10181524364049254452,['10181524364049254452'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Peripheral neuropathy induced by microtubule-targeted chemotherapies: insights into acute injury and long-term recovery', 'pub_year': '2018', 'citation': 'Cancer research 78 (3), 817-829, 2018'}",False,UCoILMwAAAAJ:p2g8aNsByqUC,61,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2673800723973324261,['2673800723973324261'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)', 'pub_year': '2013', 'citation': 'European journal of cancer 49 (13), 2910-2918, 2013'}",False,UCoILMwAAAAJ:kNdYIx-mwKoC,59,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17694135738755992882,['17694135738755992882'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer', 'pub_year': '2012', 'citation': 'Cancer chemotherapy and pharmacology 70, 899-902, 2012'}",False,UCoILMwAAAAJ:Zph67rFs4hoC,58,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8619796769865452960,['8619796769865452960'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice', 'pub_year': '2020', 'citation': 'The Journal of clinical investigation 130 (9), 4601-4606, 2020'}",False,UCoILMwAAAAJ:ILKRHgRFtOwC,54,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3715544689320212556,['3715544689320212556'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of chemotherapy-induced peripheral neurotoxicity', 'pub_year': '2020', 'citation': 'Archives of Toxicology 94, 2517-2522, 2020'}",False,UCoILMwAAAAJ:4MWp96NkSFoC,54,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17652870205311923915,['17652870205311923915'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats', 'pub_year': '2018', 'citation': 'Journal of neuroinflammation 15, 1-12, 2018'}",False,UCoILMwAAAAJ:_B80troHkn4C,54,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15859880323833212902,['15859880323833212902'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the CI‐PeriNomS study', 'pub_year': '2014', 'citation': 'Journal of the Peripheral Nervous System 19 (2), 127-135, 2014'}",False,UCoILMwAAAAJ:qUcmZB5y_30C,50,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13264905202239596281,['13264905202239596281'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?', 'pub_year': '2015', 'citation': 'American Society of Clinical Oncology Educational Book 35 (1), e553-e560, 2015'}",False,UCoILMwAAAAJ:mB3voiENLucC,47,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1298194996151905759,['1298194996151905759'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy', 'pub_year': '2020', 'citation': 'Experimental neurology 325, 113154, 2020'}",False,UCoILMwAAAAJ:epqYDVWIO7EC,46,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8113010169886979174,['8113010169886979174'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Advanced age and liability to oxaliplatin‐induced peripheral neuropathy: post hoc analysis of a prospective study', 'pub_year': '2013', 'citation': 'European Journal of Neurology 20 (5), 788-794, 2013'}",False,UCoILMwAAAAJ:KlAtU1dfN6UC,46,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=17860400597169093609,['17860400597169093609'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Genetic determinants of chronic oxaliplatin‐induced peripheral neurotoxicity: a genome‐wide study replication and meta‐analysis', 'pub_year': '2015', 'citation': 'Journal of the Peripheral Nervous System 20 (1), 15-23, 2015'}",False,UCoILMwAAAAJ:hC7cP41nSMkC,43,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14685408872864493617,['14685408872864493617'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.', 'pub_year': '2020', 'citation': 'Neuropharmacology 164, 107905, 2020'}",False,UCoILMwAAAAJ:EkHepimYqZsC,41,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11875012461274672735,['11875012461274672735'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Management of side effects in the personalized medicine era: chemotherapy-induced peripheral neuropathy', 'pub_year': '2014', 'citation': 'Pharmacogenomics in Drug Discovery and Development, 301-322, 2014'}",False,UCoILMwAAAAJ:-f6ydRqryjwC,38,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14805409581794608995,['14805409581794608995'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Platinum-drugs induced peripheral neurotoxicity: Clinical course and preclinical evidence', 'pub_year': '2019', 'citation': 'Expert opinion on drug metabolism & toxicology 15 (6), 487-497, 2019'}",False,UCoILMwAAAAJ:Fu2w8maKXqMC,37,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1823933522274222715,['1823933522274222715'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations', 'pub_year': '2022', 'citation': 'Critical reviews in oncology/hematology 171, 103575, 2022'}",False,UCoILMwAAAAJ:Ug5p-4gJ2f0C,33,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14993689218124535891,['14993689218124535891'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy', 'pub_year': '2021', 'citation': 'Proceedings of the National Academy of Sciences 118 (4), e2012685118, 2021'}",False,UCoILMwAAAAJ:35r97b3x0nAC,33,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12119611860188786016,['12119611860188786016'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The content validity of a chemotherapy-induced peripheral neuropathy patient-reported outcome measure', 'pub_year': '2017', 'citation': 'Oncology nursing forum 44 (5), 580, 2017'}",False,UCoILMwAAAAJ:KxtntwgDAa4C,33,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=754875387350366969,['754875387350366969'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients', 'pub_year': '2022', 'citation': 'Journal of the Peripheral Nervous System 27 (2), 166-174, 2022'}",False,UCoILMwAAAAJ:FPJr55Dyh1AC,29,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3371311523628353539,['3371311523628353539'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale …', 'pub_year': '2019', 'citation': 'Cancer nursing 42 (3), 179-189, 2019'}",False,UCoILMwAAAAJ:J-pR_7NvFogC,29,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11438534223945452218,['11438534223945452218'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': ""Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity"", 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24 (1), 111-119, 2019'}",False,UCoILMwAAAAJ:eq2jaN3J8jMC,28,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12480974051994195624,['12480974051994195624'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The distribution of cholinesterases in the autonomic ganglia of man and of some mammals', 'pub_year': '1961', 'citation': 'Bibl. anat.(Basel) 2, 90, 1961'}",False,UCoILMwAAAAJ:6ZxmRoH8BuwC,28,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=403935989474024774,['403935989474024774'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced peripheral neurotoxicity–outcome measures: the issue', 'pub_year': '2017', 'citation': 'Expert opinion on drug metabolism & toxicology 13 (3), 241-243, 2017'}",False,UCoILMwAAAAJ:pqnbT2bcN3wC,27,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9096097821338276200,['9096097821338276200'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurophysiological examination of dorsal sural nerve', 'pub_year': '2012', 'citation': 'Muscle & nerve 46 (6), 891-894, 2012'}",False,UCoILMwAAAAJ:ULOm3_A8WrAC,27,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4995442309511693149,['4995442309511693149'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve', 'pub_year': '2018', 'citation': 'Supportive Care in Cancer 26, 3143-3151, 2018'}",False,UCoILMwAAAAJ:1qzjygNMrQYC,25,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=529118296275705565,['529118296275705565'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Rasch‐Transformed Total Neuropathy Score clinical version (RT‐TNSc©) in patients with chemotherapy‐induced peripheral neuropathy', 'pub_year': '2015', 'citation': 'Journal of the Peripheral Nervous System 20 (3), 328-332, 2015'}",False,UCoILMwAAAAJ:wbdj-CoPYUoC,24,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12684376097642895032,['12684376097642895032'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Prospective evaluation of health care provider and patient assessments in chemotherapy-induced peripheral neurotoxicity', 'pub_year': '2021', 'citation': 'Neurology 97 (7), e660-e672, 2021'}",False,UCoILMwAAAAJ:oNZyr7d5Mn4C,23,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14846214478341151430,['14846214478341151430'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review', 'pub_year': '2020', 'citation': 'The Lancet Haematology 7 (5), e408-e417, 2020'}",False,UCoILMwAAAAJ:BwyfMAYsbu0C,19,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1740692969183283412,['1740692969183283412'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion', 'pub_year': '2022', 'citation': 'Expert review of neurotherapeutics 22 (1), 65-76, 2022'}",False,UCoILMwAAAAJ:q3CdL3IzO_QC,18,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14844640045662270540,['14844640045662270540'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Nerve supply and distribution of cholinesterase activity in the external nose of the mole', 'pub_year': '1961', 'citation': 'Zeitschrift für Zellforschung und Mikroskopische Anatomie 54 (2), 158-166, 1961'}",False,UCoILMwAAAAJ:2VqYfGB8ITEC,18,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13570750102578862215,['13570750102578862215'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Human intravenous immunoglobulin alleviates neuropathic symptoms in a rat model of paclitaxel-induced peripheral neurotoxicity', 'pub_year': '2021', 'citation': 'International journal of molecular sciences 22 (3), 1058, 2021'}",False,UCoILMwAAAAJ:k8Z6L05lTy4C,17,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13628298004476309094,['13628298004476309094'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Toxic neuropathies: chemotherapy induced peripheral neurotoxicity', 'pub_year': '2019', 'citation': 'Current opinion in neurology 32 (5), 676-683, 2019'}",False,UCoILMwAAAAJ:2KloaMYe4IUC,17,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12674082662673717306,['12674082662673717306'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models', 'pub_year': '2018', 'citation': 'European Journal of Pharmacology 840, 89-103, 2018'}",False,UCoILMwAAAAJ:PELIpwtuRlgC,17,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5297914316941956810,['5297914316941956810'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence', 'pub_year': '2023', 'citation': 'Journal of Neurology, Neurosurgery & Psychiatry 94 (11), 962-972, 2023'}",False,UCoILMwAAAAJ:dBIO0h50nwkC,14,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12159614236747808579,['12159614236747808579'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurological complications of conventional and novel anticancer treatments', 'pub_year': '2022', 'citation': 'Cancers 14 (24), 6088, 2022'}",False,UCoILMwAAAAJ:sNmaIFBj_lkC,13,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9902949021683060550,['9902949021683060550'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurons: the interplay between cytoskeleton, ion channels/transporters and mitochondria', 'pub_year': '2022', 'citation': 'Cells 11 (16), 2499, 2022'}",False,UCoILMwAAAAJ:anf4URPfarAC,13,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=16119317643673072131,['16119317643673072131'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?', 'pub_year': '2022', 'citation': 'International Journal of Molecular Sciences 23 (17), 10063, 2022'}",False,UCoILMwAAAAJ:0izLItjtcgwC,12,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6230170049521640860,['6230170049521640860'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Characteristics and patterns of pediatric chemotherapy-induced peripheral neuropathy: A systematic review', 'pub_year': '2021', 'citation': 'Cancer Treatment and Research Communications 28, 100420, 2021'}",False,UCoILMwAAAAJ:WZBGuue-350C,12,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11099367141465616488,['11099367141465616488'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Liability of the voltage‐gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin‐induced peripheral neurotoxicity', 'pub_year': '2019', 'citation': 'Journal of the Peripheral Nervous System 24 (4), 298-303, 2019'}",False,UCoILMwAAAAJ:fEOibwPWpKIC,12,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4052795549156151087,['4052795549156151087'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes', 'pub_year': '2018', 'citation': 'Neurotoxicity Research 34, 93-108, 2018'}",False,UCoILMwAAAAJ:kRWSkSYxWN8C,12,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7828743715598554383,['7828743715598554383'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Translating morphology from bench side to bed side via neurophysiology: 8-min protocol for peripheral neuropathy research', 'pub_year': '2021', 'citation': 'Journal of Neuroscience Methods 363, 109323, 2021'}",False,UCoILMwAAAAJ:-FonjvnnhkoC,10,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=677088085651169616,['677088085651169616'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Addressing the need of a translational approach in peripheral neuropathy research: Morphology meets function', 'pub_year': '2021', 'citation': 'Brain sciences 11 (2), 139, 2021'}",False,UCoILMwAAAAJ:VaXvl8Fpj5cC,10,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4648016875204287697,['4648016875204287697'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue', 'pub_year': '2013', 'citation': 'Pain management 3 (6), 417-419, 2013'}",False,UCoILMwAAAAJ:7PzlFSSx8tAC,8,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=12185021300897517429,['12185021300897517429'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Systems pharmacology modeling identifies a novel treatment strategy for bortezomib-induced neuropathic pain', 'pub_year': '2022', 'citation': 'Frontiers in Pharmacology 12, 817236, 2022'}",False,UCoILMwAAAAJ:XoXfffV-tXoC,7,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13099816936043649307,['13099816936043649307'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy', 'pub_year': '2020', 'citation': 'Expert Opinion on Drug Metabolism & Toxicology 16 (12), 1147-1158, 2020'}",False,UCoILMwAAAAJ:tYavs44e6CUC,7,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4587324659656333776,['4587324659656333776'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'on behalf of the Toxic Neuropathy Consortium of the Peripheral Nerve Society. Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue', 'pub_year': '2019', 'citation': 'J. Peripher. Nerv. Syst 24, S6-S12, 2019'}",False,UCoILMwAAAAJ:rmuvC79q63oC,7,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5944910365643424091,['5944910365643424091'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Severe, reversible nelarabine-induced neuropathy and myelopathy.', 'pub_year': '2016', 'citation': 'Journal of the Peripheral Nervous System 21 (3), 2016'}",False,UCoILMwAAAAJ:j3f4tGmQtD8C,7,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11556219467892127180,['11556219467892127180'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN)', 'pub_year': '2023', 'citation': 'Supportive Care in Cancer 31 (5), 293, 2023'}",False,UCoILMwAAAAJ:mNrWkgRL2YcC,6,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=288174752350180101,['288174752350180101'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis', 'pub_year': '2022', 'citation': 'Frontiers in Cell and Developmental Biology 10, 1055067, 2022'}",False,UCoILMwAAAAJ:umqufdRvDiIC,6,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5773043905066068662,['5773043905066068662'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Morpho-functional characterisation of the rat ventral caudal nerve in a model of axonal peripheral neuropathy', 'pub_year': '2023', 'citation': 'International Journal of Molecular Sciences 24 (2), 1687, 2023'}",False,UCoILMwAAAAJ:DUooU5lO8OsC,5,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=5394881412780339132,['5394881412780339132'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy induced peripheral neurotoxicity: Six essential articles for effective future research', 'pub_year': '2021', 'citation': 'Exp. Neurol. 337, 2021'}",False,UCoILMwAAAAJ:gsN89kCJA0AC,5,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13034766419886634189,['13034766419886634189'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Psychometric testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 using pooled Chemotherapy-Induced Peripheral Neuropathy Outcome …', 'pub_year': '2019', 'citation': 'Cancer nursing 42 (3), 179, 2019'}",False,UCoILMwAAAAJ:L7CI7m0gUJcC,4,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14559887901255144099,['14559887901255144099'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuroprotectant agents against oxaliplatin induced neurotoxicity: lackings, facts and future prospective', 'pub_year': '2013', 'citation': 'Annals of oncology 24 (5), 1418-1419, 2013'}",False,UCoILMwAAAAJ:YOwf2qJgpHMC,4,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=13642520686523336388,['13642520686523336388'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Toxic medications in Charcot–Marie–Tooth patients: A systematic review', 'pub_year': '2023', 'citation': 'Journal of the Peripheral Nervous System 28 (3), 295-307, 2023'}",False,UCoILMwAAAAJ:HtS1dXgVpQUC,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7032736216792619474,['7032736216792619474'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity', 'pub_year': '2023', 'citation': 'Toxics 11 (2), 93, 2023'}",False,UCoILMwAAAAJ:IRz6iEL74y4C,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15474132522547920520,['15474132522547920520'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': ""Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment"", 'pub_year': '2022', 'citation': 'European Journal of Cancer 161, 55-63, 2022'}",False,UCoILMwAAAAJ:ruyezt5ZtCIC,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9773841612704588223,['9773841612704588223'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Role of neurophysiology in Chemotherapy-Induced Peripheral Neuropathy (CIPN).', 'pub_year': '2020', 'citation': 'Clinical Neurophysiology: Official Journal of the International Federation …, 2020'}",False,UCoILMwAAAAJ:vbGhcppDl1QC,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9925032474925737447,['9925032474925737447'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Introduction to the Italian section for young neurologists', 'pub_year': '2019', 'citation': 'Neurological Sciences 40, 2423-2424, 2019'}",False,UCoILMwAAAAJ:NJ774b8OgUMC,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=8879280523117180042,['8879280523117180042'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Distal pain and carpal tunnel syndrome diagnosis among cashiers: a longitudinal study', 'pub_year': '2017', 'citation': 'International Archives of Occupational and Environmental Health 90, 741-746, 2017'}",False,UCoILMwAAAAJ:nb7KW1ujOQ8C,3,"https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15655868414996157769,5671962442127570381","['15655868414996157769', '5671962442127570381']",paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity', 'pub_year': '2023', 'citation': 'Scientific Reports 13 (1), 3991, 2023'}",False,UCoILMwAAAAJ:IUKN3-7HHlwC,2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=1248436540104110099,['1248436540104110099'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-Induced Peripheral Neurotoxicity (CIPN): When Epidemiological Issues Come before the Cure', 'pub_year': '2015', 'citation': 'International Journal of Cancer Research and Prevention 8 (4), 467, 2015'}",False,UCoILMwAAAAJ:4JMBOYKVnBMC,2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4295352151815249176,['4295352151815249176'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The total neuropathy score is more reliable than the national cancer institute common toxicity scale to assess stable chemotherapy-induced peripheral neurotoxicity', 'pub_year': '2011', 'citation': 'Journal of the Peripheral Nervous System 16, S42-S43, 2011'}",False,UCoILMwAAAAJ:Wp0gIr-vW9MC,2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4619749947661121053,['4619749947661121053'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Demenza e sclerosi laterale amiotrofica: da associazione insolita a continuum', 'pub_year': '2010', 'citation': 'Psicogeriatria 1, 24-32, 2010'}",False,UCoILMwAAAAJ:mVmsd5A6BfQC,2,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10155646287694836191,['10155646287694836191'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy', 'pub_year': '2024', 'citation': 'Supportive Care in Cancer 32 (1), 48, 2024'}",False,UCoILMwAAAAJ:43bX7VzcjpAC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=14257239452536967938,['14257239452536967938'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection', 'pub_year': '2022', 'citation': 'Pain, 10.1097, 2022'}",False,UCoILMwAAAAJ:jU7OWUQzBzMC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=3967292735950650114,['3967292735950650114'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Impact of COVID–19 on pre-existing neurological diseases', 'pub_year': '2021', 'citation': 'NEUROLOGY OF COVID–19 [Internet], 2021'}",False,UCoILMwAAAAJ:ClCfbGk0d_YC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10249633193307038253,['10249633193307038253'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Current Clinical Data and Future Directions', 'pub_year': '2021', 'citation': 'Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced …, 2021'}",False,UCoILMwAAAAJ:Dip1O2bNi0gC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9557974281739658382,['9557974281739658382'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy induced peripheral neurotoxicity (cipn)–beyond paresthesia and pain: The impact of sensory ataxia on quality of life', 'pub_year': '2014', 'citation': 'Abstract book of"" EANO meeting The European Association of Neuro-Oncology-9 …, 2014'}",False,UCoILMwAAAAJ:u-coK7KVo8oC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=7008173012113015856,['7008173012113015856'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Effects of Trabectedin on tumour growth and metabolism in preclinical models of HER-2 overexpressing ovarian cancer', 'pub_year': '2014', 'citation': 'Proc Intl Soc Mag Reson Med 22, 1526, 2014'}",False,UCoILMwAAAAJ:9Nmd_mFXekcC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=9800333605977694580,['9800333605977694580'],paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity', 'pub_year': '2024', 'citation': 'International Journal of Molecular Sciences 25 (12), 6552, 2024'}",False,UCoILMwAAAAJ:yxmsSjX2EkcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing', 'pub_year': '2024', 'citation': 'Journal of the Peripheral Nervous System 29 (1), 47-57, 2024'}",False,UCoILMwAAAAJ:LdasjJ6CEcoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity', 'pub_year': '2024', 'citation': 'Journal of the peripheral nervous system 29 (1), 58-71, 2024'}",False,UCoILMwAAAAJ:jgBuDB5drN8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper', 'pub_year': '2024', 'citation': 'Supportive Care in Cancer 32 (2), 117, 2024'}",False,UCoILMwAAAAJ:1taIhTC69MYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Molsidomine Provides Neuroprotection Against Vincristine-induced Peripheral Neurotoxicity Through Soluble Guanylyl Cyclase Activation', 'pub_year': '2024', 'citation': ''}",False,UCoILMwAAAAJ:MhiOAD_qIWkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS', 'pub_year': '2024', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 29 (S2), 38-39, 2024'}",False,UCoILMwAAAAJ:XUvXOeBm_78C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON?', 'pub_year': '2024', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 29 (S2), 11-11, 2024'}",False,UCoILMwAAAAJ:L1USKYWJimsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Peer-to-peer Tuturing Activities in Human Anatomy Exploiting Digital Tools', 'pub_year': '2024', 'citation': 'Abstract book, 2024'}",False,UCoILMwAAAAJ:CB2v5VPnA5kC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin-induced peripheral neurotoxicity: molecular insights', 'pub_year': '2024', 'citation': ''}",False,UCoILMwAAAAJ:owLR8QvbtFgC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization', 'pub_year': '2024', 'citation': ''}",False,UCoILMwAAAAJ:PYBJJbyH-FwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)—a …', 'pub_year': '2024', 'citation': 'Supportive Care in Cancer 32 (3), 2024'}",False,UCoILMwAAAAJ:7wO8s98CvbsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models.', 'pub_year': '2023', 'citation': 'Brain Research Bulletin, 110769, 2023'}",False,UCoILMwAAAAJ:1lhNe0rCu4AC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Histone deacetylases inhibitors to overcome Chemotherapy-induced peripheral neuropathy.', 'pub_year': '2023', 'citation': 'Italian Journal of Anatomy and Embryology 127 (S1), 152-154, 2023'}",False,UCoILMwAAAAJ:BzfGm06jWhQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models.', 'pub_year': '2023', 'citation': 'Italian Journal of Anatomy and Embryology 127 (S1), 11-13, 2023'}",False,UCoILMwAAAAJ:ALROH1vI_8AC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'HDAC inhibitors as antineoplastic and neuroprotective drugs: in vitro assessment', 'pub_year': '2023', 'citation': ''}",False,UCoILMwAAAAJ:wKETBy42zhYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY', 'pub_year': '2023', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 28 (S4), 141-142, 2023'}",False,UCoILMwAAAAJ:7H_MAutzIkAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy', 'pub_year': '2023', 'citation': ''}",False,UCoILMwAAAAJ:MpfHP-DdYjUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin Induced Peripheral Neurotoxicity: From Bed to Bench Side and Vice Versa', 'pub_year': '2023', 'citation': 'Abstract book, 2023'}",False,UCoILMwAAAAJ:lgwcVrK6X84C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Effect of nonlinear exercise program through mHealth System (ATOPE+) on isokinetic strenght in patients with breast cancer undergoing medical treatments', 'pub_year': '2023', 'citation': 'Abstract book, 2023'}",False,UCoILMwAAAAJ:otzGkya1bYkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Peripheral Neurotoxic Medications in CMT Patients', 'pub_year': '2023', 'citation': 'Meeting proceedings, 2023'}",False,UCoILMwAAAAJ:wMgC3FpKEyYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin', 'pub_year': '2023', 'citation': 'Meeting proceedings, 2023'}",False,UCoILMwAAAAJ:QD3KBmkZPeQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Histone deacetylases inhibitors: a new frontier for neuroprotection?', 'pub_year': '2023', 'citation': ''}",False,UCoILMwAAAAJ:0CzhzZyukY4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced peripheral neurotoxicity (CIPN): why should we care?', 'pub_year': '2023', 'citation': 'Meeting proceedings, 2023'}",False,UCoILMwAAAAJ:r_AWSJRzSzQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI', 'pub_year': '2023', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 28 (S2), 4-4, 2023'}",False,UCoILMwAAAAJ:yFnVuubrUp4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY (CIPN): SOCIO-ECONOMIC BURDEN–A PILOT STUDY', 'pub_year': '2023', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 28 (S2), 4-5, 2023'}",False,UCoILMwAAAAJ:bKqednn6t2AC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy.', 'pub_year': '2022', 'citation': 'Italian Journal of Anatomy and Embryology 126 (S1), 218-221, 2022'}",False,UCoILMwAAAAJ:a9-T7VOCCH8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'DRG SATELLITE GLIAL CELLS: INVOLVEMENT IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27, S25-S26, 2022'}",False,UCoILMwAAAAJ:8d8msizDQcsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'MORPHO-FUNCTIONAL CHARACTERIZATION OF THE CAUDAL NERVE TO REFINE ASSESSMENT OF PERIPHERAL NEUROPATHY IN RAT MODELS', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27, S7-S8, 2022'}",False,UCoILMwAAAAJ:GtLg2Ama23sC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'INVESTIGATING THE SATELLITE GLIAL CELLS INVOLVEMENT IN CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27, S29-S30, 2022'}",False,UCoILMwAAAAJ:Ri6SYOTghG4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Exploiting the double-effect of HDACi as therapeutic tool against cancer', 'pub_year': '2022', 'citation': ''}",False,UCoILMwAAAAJ:LhH-TYMQEocC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity', 'pub_year': '2022', 'citation': 'NeuroMI 2022-Meeting proceedings, 2022'}",False,UCoILMwAAAAJ:DJbcl8HfkQkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin', 'pub_year': '2022', 'citation': 'Italian Journal of Anatomy and Embryology 126, 217-217, 2022'}",False,UCoILMwAAAAJ:HtEfBTGE9r8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity', 'pub_year': '2022', 'citation': 'Pharmacogenomics in Drug Discovery and Development, 95-140, 2022'}",False,UCoILMwAAAAJ:NXb4pA-qfm4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27 (S3), 158-159, 2022'}",False,UCoILMwAAAAJ:FAceZFleit8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27 (S3), 51-52, 2022'}",False,UCoILMwAAAAJ:_FM0Bhl9EiAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models.', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27 (S2), 3-4, 2022'}",False,UCoILMwAAAAJ:bz8QjSJIRt4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy Induced Peripheral Neurotoxicy: why should we care?', 'pub_year': '2022', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 27 (S2), 3-3, 2022'}",False,UCoILMwAAAAJ:kh2fBNsKQNwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Serum neurofilament light chain as a blood biomarker of severity in paclitaxel-induced peripheral neurotoxicity', 'pub_year': '2021', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (3), 362-362, 2021'}",False,UCoILMwAAAAJ:PoWvk5oyLR8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Macrophage infiltration contributes differently to axonal degeneration after chemotherapy treatment: an experimental study.', 'pub_year': '2021', 'citation': 'Italian Journal of Anatomy & Embryology/Archivio Italiano di Anatomia Ed …, 2021'}",False,UCoILMwAAAAJ:9pM33mqn1YgC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2021', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (S1), 18-19, 2021'}",False,UCoILMwAAAAJ:prdVHNxh-e8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Seizure-Related 6 Homolog Like 2 Autoimmunity: Neurologic Syndrome and Antibody Effects', 'pub_year': '2021', 'citation': ''}",False,UCoILMwAAAAJ:7Hz3ACDFbsoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN', 'pub_year': '2021', 'citation': 'EUROPEAN JOURNAL OF HISTOCHEMISTRY 65, 2021'}",False,UCoILMwAAAAJ:kVjdVfd2voEC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity.', 'pub_year': '2021', 'citation': 'Abstract book, 2021'}",False,UCoILMwAAAAJ:v1_lew4L6wgC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Presenting International Chemotherapy induced peripheral neurotoxicity (CIPN) assessment and validation study (ICAVS)', 'pub_year': '2021', 'citation': 'Abstract book, 2021'}",False,UCoILMwAAAAJ:U4n9YNQMCAIC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2021', 'citation': 'EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021'}",False,UCoILMwAAAAJ:zCSUwVk65WsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY', 'pub_year': '2021', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (S1), S5-S5, 2021'}",False,UCoILMwAAAAJ:OcBU2YAGkTUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Practical Tips for a Rapid and Efficient CIPN Patient Evaluation', 'pub_year': '2021', 'citation': ''}",False,UCoILMwAAAAJ:4vMrXwiscB8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection?', 'pub_year': '2021', 'citation': 'Italian Journal of Anatomy and Embryology 125, 125-125, 2021'}",False,UCoILMwAAAAJ:4fGpz3EwCPoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': '7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model', 'pub_year': '2021', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 26 (3), 368-368, 2021'}",False,UCoILMwAAAAJ:SpbeaW3--B0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function. Brain Sci. 2021, 11, 139', 'pub_year': '2021', 'citation': 's Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021'}",False,UCoILMwAAAAJ:kz9GbA2Ns4gC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Pathogenic role of D2-tubulin in bortezomib induced peripheral neuropathy', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 560-561, 2020'}",False,UCoILMwAAAAJ:LI9QrySNdTsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 520-521, 2020'}",False,UCoILMwAAAAJ:lmc2jWPfTJgC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Antinociceptive efficacy of IVIg in the treatment of paclitaxel-induced neuropathic pain in a rat model', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 498-499, 2020'}",False,UCoILMwAAAAJ:MLfJN-KU85MC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Molsidomine provides neuroprotection against vincristine-induced peripheral neuropathy through soluble guanylyl cyclase activation', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 568-569, 2020'}",False,UCoILMwAAAAJ:kuK5TVdYjLIC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'SCALES: PERIPHERAL NERVES', 'pub_year': '2020', 'citation': 'Effects of Cancer Treatment on the Nervous System, Volume 1, 198-232, 2020'}",False,UCoILMwAAAAJ:TIZ-Mc8IlK0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Differential Contribution of Neuronal Uptake Transporters to Oxaliplatin Peripheral Neurotoxicity', 'pub_year': '2020', 'citation': 'The FASEB Journal 34 (S1), 1-1, 2020'}",False,UCoILMwAAAAJ:ML0RJ9NH7IQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity', 'pub_year': '2020', 'citation': 'Abstract book di"" Morfologia e dintorni"" 3° incontro nazionale 26 settembre 2020, 2020'}",False,UCoILMwAAAAJ:IaI1MmNe2tcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN)', 'pub_year': '2020', 'citation': 'Abstract book del 3° Incontro Morfologia e dintorni, 2020'}",False,UCoILMwAAAAJ:7BrZ7Jt4UNcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection.', 'pub_year': '2020', 'citation': 'Abstract book, 2020'}",False,UCoILMwAAAAJ:PaBasH6fAo0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back.', 'pub_year': '2020', 'citation': 'ABSTRACT BOOK, 2020'}",False,UCoILMwAAAAJ:ODE9OILHJdcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'A possible biomarker for paclitaxel-induced peripheral neurotoxicity: Neurofilament light chain serum levels monitoring', 'pub_year': '2020', 'citation': 'Abstract book, 2020'}",False,UCoILMwAAAAJ:cWzG1nlazyYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Guillain–Barré Syndrome Associated with COVID-19', 'pub_year': '2020', 'citation': 'Abstract book, 2020'}",False,UCoILMwAAAAJ:HIFyuExEbWQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery.', 'pub_year': '2020', 'citation': 'Meeting proceedings, 2020'}",False,UCoILMwAAAAJ:QYdC8u9Cj1oC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 488-489, 2020'}",False,UCoILMwAAAAJ:tuHXwOkdijsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study.', 'pub_year': '2020', 'citation': 'MEETING PROCEEDINGS. 25 (4), 481-482, 2020'}",False,UCoILMwAAAAJ:b1wdh0AR-JQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Responsiveness and Minimal Clinical Important Difference (MCID) of the Total Neuropathy Score clinical and nurse versions in CIPN', 'pub_year': '2020', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 502-502, 2020'}",False,UCoILMwAAAAJ:EYYDruWGBe4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': '37 Reducing overtreatment of early stage ovarian cancer: strategies implementation by a mirna-driven prognostic assessment', 'pub_year': '2019', 'citation': 'International Journal of Gynecologic Cancer 29 (Suppl 3), 2019'}",False,UCoILMwAAAAJ:uJ-U7cs_P_0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'NERVE EXCITABILITY TESTING IN ANIMAL MODELS OF OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: ION CHANNEL DYSFUNCTION AS A POSSIBLE PATHOGENETIC MECHANISM.', 'pub_year': '2019', 'citation': 'Università degli Studi di Milano-Bicocca, 2019'}",False,UCoILMwAAAAJ:lvd772isFD0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity', 'pub_year': '2019', 'citation': 'PNS MEETING PROCEEDINGS, 2019'}",False,UCoILMwAAAAJ:PVgj2kMGcgYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE.', 'pub_year': '2019', 'citation': 'MEETING PROCEEDINGS NEUMI2019, 2019'}",False,UCoILMwAAAAJ:6yz0xqPARnAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model', 'pub_year': '2019', 'citation': 'MEETING PROCEEDINGS-PNS MEETING 2019, 2019'}",False,UCoILMwAAAAJ:LgRImbQfgY4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models.', 'pub_year': '2019', 'citation': 'PNS MEETING PROCEEDINGS, 2019'}",False,UCoILMwAAAAJ:nZcligLrVowC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules', 'pub_year': '2019', 'citation': 'Abstract book, 2019'}",False,UCoILMwAAAAJ:a3BOlSfXSfwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Sensory-motor paclitaxel polyneuropathy characterization in a rat model', 'pub_year': '2019', 'citation': 'PNS 2019 MEETING PROCEEDINGS, 2019'}",False,UCoILMwAAAAJ:yqoGN6RLRZoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy induced peripheral neurotoxicity: the search for the ideal outcome measure', 'pub_year': '2019', 'citation': 'PNS MEETING 2019-MEETING PROCEEDINGS, 2019'}",False,UCoILMwAAAAJ:yMeIxYmEMEAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Liability Of The Voltage-Gated Potassium Channel SK3 Repeat Polymorphism To Acute Oxaliplatin-Induced Peripheral Neurotoxicity', 'pub_year': '2019', 'citation': 'PNS MEETING 2019 ABSTRACT BOOK, 2019'}",False,UCoILMwAAAAJ:3htObqc8RwsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models', 'pub_year': '2019', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24 (supp 1), S4-S4, 2019'}",False,UCoILMwAAAAJ:W5xh706n7nkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy Induced Peripheral Neurotoxicity (CIPN): neurological burden from a physician and patient point of view', 'pub_year': '2019', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24 (suppl 1), S3-S3, 2019'}",False,UCoILMwAAAAJ:_Ybze24A_UAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to …', 'pub_year': '2019', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24 (suppl 1), S3-S4, 2019'}",False,UCoILMwAAAAJ:uLbwQdceFCQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats', 'pub_year': '2019', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24 (suppl 1), S11-S12, 2019'}",False,UCoILMwAAAAJ:hkOj_22Ku90C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity', 'pub_year': '2019', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24 (supp 1), S36-S36, 2019'}",False,UCoILMwAAAAJ:PR6Y55bgFSsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate prevents oxaliplatin acute effects on axonal excitability', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (4), 312-312, 2018'}",False,UCoILMwAAAAJ:9vf0nzSNQJEC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: A RAT MODEL THAT REPRODUCES ACUTE AND CHRONIC PHENOMENA', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23, S4-S5, 2018'}",False,UCoILMwAAAAJ:olpn-zPbct0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity', 'pub_year': '2018', 'citation': 'Libro atti meeting Neuromi2018, 2018'}",False,UCoILMwAAAAJ:Bg7qf7VwUHIC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity.', 'pub_year': '2018', 'citation': 'Libro degli abstract del XXV Convegno annuale dell’Associazione Italiana per …, 2018'}",False,UCoILMwAAAAJ:artPoR2Yc-kC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY.', 'pub_year': '2018', 'citation': 'Proceedings Meeting 2018, 2018'}",False,UCoILMwAAAAJ:5icHVeHT4IsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Novità in materia di neuropatie periferiche', 'pub_year': '2018', 'citation': 'Atti del Convegno"" La richiesta di competenza neurologica nel prossimo …, 2018'}",False,UCoILMwAAAAJ:OP4eGU-M3BUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena', 'pub_year': '2018', 'citation': 'Abstract"" VIII riunione annuale ASNP""., 2018'}",False,UCoILMwAAAAJ:fFSKOagxvKUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Blood NfL as a potential axonal damage marker in different CIPN rat models.', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (4), 398-398, 2018'}",False,UCoILMwAAAAJ:dTyEYWd-f8wC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The Link between Bench and Bed-Side:“clinical” neurophysiological approach to a rat model of neuropathy', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (4), 252-252, 2018'}",False,UCoILMwAAAAJ:Mojj43d5GZwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (Supplement), S28-S29, 2018'}",False,UCoILMwAAAAJ:t6usbXjVLHcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models', 'pub_year': '2018', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (S1), 17-17, 2018'}",False,UCoILMwAAAAJ:XiVPGOgt02cC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE.', 'pub_year': '2018', 'citation': 'Atti congresso"" VIII riunione annuale ASNP"", 2018'}",False,UCoILMwAAAAJ:bnK-pcrLprsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Targeting oatp1b2 to ameliorate paclitaxel-induced chronic peripheral neuropathy', 'pub_year': '2018', 'citation': 'CLINICAL PHARMACOLOGY & THERAPEUTICS 103, S8-S8, 2018'}",False,UCoILMwAAAAJ:V3AGJWp-ZtQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Dolore neuropatico postchemio e radioterapia', 'pub_year': '2017', 'citation': 'Abstract book del 12° convegno trivento dei centri di terapia del dolore e …, 2017'}",False,UCoILMwAAAAJ:jL-93Qbq4QoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Ion Channel Dysfunction and Axonal Hyperexcitability in Animal Models: a Possible Key to Peripheral Neurotoxicity', 'pub_year': '2017', 'citation': 'Abstract"" Festival della luce di Como-2017"", 2017'}",False,UCoILMwAAAAJ:F1b5ZUV5XREC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy', 'pub_year': '2017', 'citation': 'Abstract book Modelli animali e medicina traslazionale: qualità e …, 2017'}",False,UCoILMwAAAAJ:BJbdYPG6LGMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing.', 'pub_year': '2017', 'citation': 'Abstract book AISAL 2017, 2017'}",False,UCoILMwAAAAJ:gVv57TyPmFsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'OXALIPLATIN INDUCED PERIPHERAL NEUROTOXICITY: NERVE EXCITABILITY TESTING FULL PROFILE IN A LONG TERM TOXICITY ANIMAL STUDY.', 'pub_year': '2017', 'citation': ""XLVIII Congresso Societa'Italiana Di Neurologia book of abstract, 2017""}",False,UCoILMwAAAAJ:Aul-kAQHnToC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Advanced neurophysiology-a translational approach to neuropathy and neuropathic pain', 'pub_year': '2017', 'citation': '“International Symposium on Neurobiology”, a joint meeting between the …, 2017'}",False,UCoILMwAAAAJ:Ehil0879vHcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment', 'pub_year': '2017', 'citation': 'Abstract Book NeuroMi 2017, 2017'}",False,UCoILMwAAAAJ:P7Ujq4OLJYoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Breaking the wall of Chemotherapy Neurotox', 'pub_year': '2017', 'citation': 'Abstract falling walls, 2017'}",False,UCoILMwAAAAJ:HeT0ZceujKMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Animal Models for the Study of Human Central and Peripheral Nervous System Diseases', 'pub_year': '2017', 'citation': 'Abstract Modelli animali e medicina traslazionale: qualità e riproducibilità …, 2017'}",False,UCoILMwAAAAJ:KbBQZpvPDL4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity', 'pub_year': '2017', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 22 (3), 231-231, 2017'}",False,UCoILMwAAAAJ:SP6oXDckpogC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy', 'pub_year': '2017', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 22 (3), 238-239, 2017'}",False,UCoILMwAAAAJ:UxriW0iASnsC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY', 'pub_year': '2017', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 22 (suppl 1), S5-S5, 2017'}",False,UCoILMwAAAAJ:P5F9QuxV20EC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY', 'pub_year': '2017', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 22, S8-S8, 2017'}",False,UCoILMwAAAAJ:1sJd4Hv_s6UC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity', 'pub_year': '2017', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 22 (Supplement 1), S4-S44, 2017'}",False,UCoILMwAAAAJ:CHSYGLWDkRkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuropathy and myelopathy: case report', 'pub_year': '2016', 'citation': 'Reactions 1631, 138-10, 2016'}",False,UCoILMwAAAAJ:HoB7MX3m0LUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity-Neurophysiology: the Link between Bed and Bench"" side""', 'pub_year': '2016', 'citation': 'Università Degli Studi di Milano-Bicocca, 2016'}",False,UCoILMwAAAAJ:AHdEip9mkN0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'MR309/E-52862, a first-in-class sigma-1 receptor antagonist, in oxaliplatin-induced peripheral neuropathy. An exploratory Phase II clinical trial', 'pub_year': '2016', 'citation': 'Abstract Book of"" 16th World Congress on pain 2016 International Association …, 2016'}",False,UCoILMwAAAAJ:4xDN1ZYqzskC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Pharmacokinetics of IVIg in Wistar rats', 'pub_year': '2016', 'citation': 'XXIII Convegno Annuale AISAL, 2016'}",False,UCoILMwAAAAJ:uDGL6kOW6j0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Patologie della giunzione neuromuscolare', 'pub_year': '2016', 'citation': 'CORE CURRICULUM, 437-446, 2016'}",False,UCoILMwAAAAJ:2tRrZ1ZAMYUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy Induced Peripheral Neurotoxicity (CIPN)', 'pub_year': '2016', 'citation': 'Abstract Book"" V Giornata dello Specializzando in Neurologia"", 2016'}",False,UCoILMwAAAAJ:tH6gc1N1XXoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin Induced Peripheral Neurotoxicity: what we know and what we need', 'pub_year': '2016', 'citation': 'Abstract Book of"" VI European Conference on Cured and Chronic Cancer Patients"", 2016'}",False,UCoILMwAAAAJ:gKiMpY-AVTkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin induced peripheral neurotoxicity–a neurophysiological translational approach', 'pub_year': '2016', 'citation': 'Quinta giornata dello specializzando in neurologia, 2016'}",False,UCoILMwAAAAJ:fbc8zXXH2BUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY.', 'pub_year': '2016', 'citation': 'Libro degli abstract del XLVII Congresso della società italiana di neurologia, 2016'}",False,UCoILMwAAAAJ:ZzlSgRqYykMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice', 'pub_year': '2016', 'citation': 'Abstract book of Neuroscience 2016 meeting, 2016'}",False,UCoILMwAAAAJ:8xutWZnSdmoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'How to assess models of oxaliplatin induced peripheral neurotoxicity–a neurophysiological translational approach', 'pub_year': '2016', 'citation': 'Libro degli atti del XLVII congresso della società italiana di neurologia …, 2016'}",False,UCoILMwAAAAJ:F9fV5C73w3QC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Translational approach to chemotherapy induced peripheral neurotoxicity (cipn)–neurophysiology as the link between bench and bed-side', 'pub_year': '2016', 'citation': 'Abstracts for the Second International Meeting of the Milan Center for …, 2016'}",False,UCoILMwAAAAJ:bEWYMUwI8FkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'A CASE OF TAXANE-RELATED PERIPHERAL NEUROTOXICITY IN A CMT1A PATIENT', 'pub_year': '2016', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 21, S3-S3, 2016'}",False,UCoILMwAAAAJ:iH-uZ7U-co4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'CROSS-SECTIONAL STUDY OF A POPULATION OF FABRY DISEASE PATIENTS: PILOT STUDY FOR A FABRY-RELATED NEUROPATHY REGISTRY', 'pub_year': '2015', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 20, S1-S1, 2015'}",False,UCoILMwAAAAJ:hFOr9nPyWt4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Oxaliplatin neurotoxicity: morpho-functional approach', 'pub_year': '2015', 'citation': 'Education 2019, 2015'}",False,UCoILMwAAAAJ:cK4Rrx0J3m0C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy Induced Peripheral Neurotoxicity. An Issue that should not be forgotten: Neuropathic Pain', 'pub_year': '2015', 'citation': 'Abstract Book of First Joint Meeting of Societe Francophone du Nerf …, 2015'}",False,UCoILMwAAAAJ:_OXeSy2IsFwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Following up the long-term Course of Oxaliplatin-Induced Peripheral Neurotoxicity', 'pub_year': '2015', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 20 (2), 94-94, 2015'}",False,UCoILMwAAAAJ:RHpTSmoSYBkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'O3. 05CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY (CIPN): THE IMPACT OF SENSORY ATAXIA ON PATIENT REPORTED ASSESSMENT OF MOTOR IMPAIRMENT', 'pub_year': '2014', 'citation': 'Neuro-oncology 16 (Suppl 2), ii6, 2014'}",False,UCoILMwAAAAJ:IWHjjKOFINEC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Severe neurotoxicity: case report', 'pub_year': '2014', 'citation': 'Reactions 1514, 31-16, 2014'}",False,UCoILMwAAAAJ:SeFeTyx0c_EC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy.', 'pub_year': '2014', 'citation': 'Conference proceedings of"" ENFS (European Federation of Neurological …, 2014'}",False,UCoILMwAAAAJ:4DMP91E08xMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves', 'pub_year': '2014', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 19 (Supplement), S1-S1, 2014'}",False,UCoILMwAAAAJ:_kc_bZDykSQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'PROVIDER PERCEPTIONS OF CLINICAL NEUROPATHY EXAMINATION USEFULNESS', 'pub_year': '2013', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 18, 42-43, 2013'}",False,UCoILMwAAAAJ:M3ejUd6NZC8C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The lectin pathway as a therapeutic target in stroke', 'pub_year': '2013', 'citation': 'NEUROLOGICAL SCIENCES 34, 269, 2013'}",False,UCoILMwAAAAJ:CaZNVDsoPx4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Epidemiologia e clinica della CIPN', 'pub_year': '2013', 'citation': 'Libro degli atti del 36° Congresso Nazionale AISD, 2013'}",False,UCoILMwAAAAJ:Ak0FvsSvgGUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Dorsal sural nerve conduction study as an early predictor for oxaliplatin-related neuropathy', 'pub_year': '2013', 'citation': 'JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 18, 1, 2013'}",False,UCoILMwAAAAJ:aqlVkmm33-oC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study.', 'pub_year': '2012', 'citation': 'Journal of Clinical Oncology 30 (15_suppl), 9090-9090, 2012'}",False,UCoILMwAAAAJ:QIV2ME_5wuYC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Le malattie cerebrovascolari', 'pub_year': '2012', 'citation': 'Elementi di neurologia per odontoiatria, 107-126, 2012'}",False,UCoILMwAAAAJ:NyGDZy8z5eUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Major issue in chemotherapy-induced peripheral neuropathy (cipn): lack of standardized measurement scales. ciperinoms study: validity and reliability in cipn assessment', 'pub_year': '2012', 'citation': 'I SUPPLEMENTI DI TUMORI, 2012'}",False,UCoILMwAAAAJ:4X0JR2_MtJMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'TUMORI PRIMITIVI E METASTATICI DEL SISTEMA NERVOSO', 'pub_year': '2012', 'citation': 'Harrison, Principi di Medicina Interna 2, 3347-3358, 2012'}",False,UCoILMwAAAAJ:sJsF-0ZLhtgC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Chemotherapy-induced Peripheral Neuropathy', 'pub_year': '2012', 'citation': 'Abstract Book of the 2012 Mediterrean Area Neurological Socities Meeting, 2012'}",False,UCoILMwAAAAJ:vDZJ-YLwNdEC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients', 'pub_year': '2012', 'citation': ''}",False,UCoILMwAAAAJ:nVrZBo8bIpAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Neuropatie periferiche', 'pub_year': '2012', 'citation': 'Harrison-Principi di medicina interna 2, 3413-3436, 2012'}",False,UCoILMwAAAAJ:5MTHONV0fEkC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'When progressive dysphagia could be related to an “old friend”–a case report', 'pub_year': '2012', 'citation': 'NEUROLOGICAL SCIENCES, 2012'}",False,UCoILMwAAAAJ:GFxP56DSvIMC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': '857 MicroRNA Predictor of Early Relapse in Advanced Stage Ovarian Cancer Patients', 'pub_year': '2012', 'citation': 'european journal of cancer, S206, 2012'}",False,UCoILMwAAAAJ:5ugPr518TE4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy–Incidence and Facts About the “Real Life” Population And Actual Dose', 'pub_year': '2012', 'citation': 'Abstract book of"" International Symposium on Platinum Coordination Compounds …, 2012'}",False,UCoILMwAAAAJ:_Qo2XoVZTnwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Elementi di Neurologia per Odontoiatria', 'pub_year': '2012', 'citation': 'McGraw-Hill, 2012'}",False,UCoILMwAAAAJ:HDshCWvjkbEC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The Pi3K Inhibitor Ly294002 Downregulates Akt Phosphorylation & Reduces Cell Proliferation Without Decreasing the Phosphocholine Level in Ovarian Cancer Cells', 'pub_year': '2011', 'citation': 'Proc. Intl. Soc. Mag. Reson. Med 19, 1001, 2011'}",False,UCoILMwAAAAJ:86PQX7AUzd4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy', 'pub_year': '2010', 'citation': 'NEUROLOGICAL SCIENCES 31 (Supplement), 196-196, 2010'}",False,UCoILMwAAAAJ:OR75R8vi5nAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Sclerosi laterale amiotrofica e demenza: associazione insolita o continuum', 'pub_year': '2009', 'citation': 'Psicogeriatria, 2009'}",False,UCoILMwAAAAJ:ZeXyd9-uunAC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Complement activation by combined use of chimeric anti-FR and anti-mCRP antibodies as an efficient effector system in the treatment of ovarian carcinoma', 'pub_year': '2006', 'citation': 'MOLECULAR IMMUNOLOGY 43 (1-2), 184-184, 2006'}",False,UCoILMwAAAAJ:Y5dfb0dijaUC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': ""Department of Anatomy, The Medical School, King's College, Newcastle upon Tyne, England NERVE SUPPLY AND DISTRIBUTION OF CHOLINESTERASE ACTIVITY IN THE EXTERNAL NOSE OF THE MOLE"", 'pub_year': '1961', 'citation': 'Cell and tissue research 54, 158-166, 1961'}",False,UCoILMwAAAAJ:WC23djZS0W4C,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'NEUROHISTOLOGICAL AND CHOLINESTERASE STUDIES OF NERVE ENDINGS IN NOSE OF MOLE', 'pub_year': '1961', 'citation': 'ANATOMICAL RECORD 139 (2), 201-&, 1961'}",False,UCoILMwAAAAJ:_5tno0g5mFcC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Genomic Expression and Biochemical Characterization of Enzymes Contributing to the Phosphocholine MRS Signal in Ovary Cancer', 'citation': ''}",False,UCoILMwAAAAJ:PVjk1bu6vJQC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Multiparametric Non Invasive MRS Evalutation of Cisplatin Treatment in Ovarian Cancer', 'citation': ''}",False,UCoILMwAAAAJ:5qfkUJPXOUwC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Voltage-Gated Sodium Channel Polymorphisms Play a Pivotal Role in the Development of Oxaliplatin-Induced Peripheral Neurotoxicity Results From a Prospective Multicenter Study', 'citation': ''}",False,UCoILMwAAAAJ:tkaPQYYpVKoC,0,,,paola alberti
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop', 'pub_year': '2022', 'citation': 'Basic Research in Cardiology 117 (1), 39, 2022'}",False,rgdDTUoAAAAJ:UeHWp8X0CEIC,31,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=2667582061159547745,['2667582061159547745'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Cardiovascular care in sub-Saharan Africa during the COVID-19 crisis: lessons from the global experience', 'pub_year': '2020', 'citation': 'Cardiovascular Journal of Africa 31 (3), 113-115, 2020'}",False,rgdDTUoAAAAJ:u5HHmVD_uO8C,6,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=15016771582990618941,['15016771582990618941'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Remote ischaemic conditioning in STEMI patients in sub-Saharan AFRICA: rationale and study design for the RIC-AFRICA trial', 'pub_year': '2023', 'citation': 'Cardiovascular Drugs and Therapy 37 (2), 299-305, 2023'}",False,rgdDTUoAAAAJ:2osOgNQ5qMEC,5,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=10856815557492386501,['10856815557492386501'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19', 'pub_year': '2023', 'citation': 'Molecular genetics and metabolism 138 (4), 107552, 2023'}",False,rgdDTUoAAAAJ:Tyk-4Ss8FVUC,4,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=4706557205793073493,['4706557205793073493'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19', 'pub_year': '2022', 'citation': 'Cardiovascular Drugs and Therapy 36 (5), 925-930, 2022'}",False,rgdDTUoAAAAJ:9yKSN-GCB0IC,3,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=6944672245134788623,['6944672245134788623'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Effect of remote ischaemic conditioning on the inflammatory cytokine cascade of COVID-19 (RIC in COVID-19): a randomized controlled trial', 'pub_year': '2022', 'citation': 'Cardiovascular Drugs and Therapy, 1-13, 2022'}",False,rgdDTUoAAAAJ:zYLM7Y9cAGgC,1,https://scholar.google.com/scholar?oi=bibs&hl=en&cites=11825218091502858167,['11825218091502858167'],kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 (Jun, 10.1007 …', 'pub_year': '2022', 'citation': 'CARDIOVASCULAR DRUGS AND THERAPY 36 (5), 931-931, 2022'}",False,rgdDTUoAAAAJ:W7OEmFMy1HYC,0,,,kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19', 'pub_year': '2021', 'citation': 'Cardiovascular Drugs and Therapy, 2021'}",False,rgdDTUoAAAAJ:YsMSGLbcyi4C,0,,,kishal lukhna
Publication,AUTHOR_PUBLICATION_ENTRY,"{'title': 'The utility of the 1994 versus the revised 2010 arrhythmogenic right ventricular cardiomyopathy (ARVC) task force diagnostic criteria for identifying mutation-positive probands …', 'pub_year': '2021', 'citation': ''}",False,rgdDTUoAAAAJ:d1gkVwhDpl0C,0,,,kishal lukhna
